PCSK9 drugs for Homozygous Familial Hypercholesterolemia
3 tracked PCSK9 drugs in the Homozygous Familial Hypercholesterolemia race. The class explanation lives on the PCSK9 page; the full indication pipeline across every mechanism is on the Homozygous Familial Hypercholesterolemia page.
3 approved / phase 4
Head-to-head evidence: Alirocumab vs Evolocumab · Alirocumab vs Inclisiran · Evolocumab vs Inclisiran